tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market
Advertisement

Xvivo Perfusion AB (XVIPF) Technical Analysis

Compare
10 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Xvivo Perfusion AB’s (XVIPF) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Xvivo Perfusion AB is a Sell.
Xvivo Perfusion AB’s (XVIPF) 20-Day exponential moving average is 18.43, while Xvivo Perfusion AB’s (XVIPF) share price is $19.61, making it a Buy.
Xvivo Perfusion AB’s (XVIPF) 50-Day exponential moving average is 18.78, while Xvivo Perfusion AB’s (XVIPF) share price is $19.61, making it a Buy.

Xvivo Perfusion AB (XVIPF) Pivot Points

Nov 30, 2025, 01:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.70
19.70
19.70
19.70
19.70
19.70
19.70
Fibonacci
19.70
19.70
19.70
19.70
19.70
19.70
19.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xvivo Perfusion AB (XVIPF) Moving Averages

Nov 30, 2025, 01:19 PM
Period
Simple
Exponential
MA5
18.92Buy
19.06Buy
MA10
18.12Buy
18.60Buy
MA20
18.25Buy
18.43Buy
MA50
18.42Buy
18.78Buy
MA100
19.40Buy
20.89Sell
MA200
26.51Sell
26.97Sell
Xvivo Perfusion AB’s (XVIPF) 10-Day exponential moving average is 18.60, while Xvivo Perfusion AB’s (XVIPF) share price is $19.61, making it a Buy.
Xvivo Perfusion AB’s (XVIPF) 100-Day exponential moving average is 20.89, while Xvivo Perfusion AB’s (XVIPF) share price is $19.61, making it a Sell.
Xvivo Perfusion AB’s (XVIPF) stock price is $19.61 and Xvivo Perfusion AB’s (XVIPF) 50-day simple moving average is 18.42, creating a Buy signal.
Xvivo Perfusion AB’s (XVIPF) stock price is $19.61 and Xvivo Perfusion AB’s (XVIPF) 100-day simple moving average is 19.40, creating a Buy signal.
Xvivo Perfusion AB’s (XVIPF) stock price is $19.61 and Xvivo Perfusion AB’s (XVIPF) 200-day simple moving average is 26.51, creating a Sell signal.

Xvivo Perfusion AB (XVIPF) Technical Indicators

Nov 30, 2025, 01:19 PM
Name
Value
Implied Action
RSI (14)
62.08
Neutral
STOCH (9,6)
94.00
Sell
STOCHRSI (14)
94.00
Sell
MACD (12,26)
0.09
Sell
ADX (14)
16.59
Buy
Williams %R
-8.22
Sell
CCI (14)
111.60
Sell
ATR (14)
0.67
-
Ultimate Oscillator
64.10
Neutral
ROC
10.42
Buy
Xvivo Perfusion AB’s (XVIPF) Relative Strength Index (RSI) is 62.08, creating a Neutral signal.
Xvivo Perfusion AB’s (XVIPF) Trend Strength Indicator (ADX) is 16.59, creating a Buy signal.
Xvivo Perfusion AB’s (XVIPF) Commodity Channel Index (CCI) is 111.60, creating a Sell signal.
Xvivo Perfusion AB’s (XVIPF) Price Rate of Change (ROC) is 10.42, creating a Buy signal.

FAQ

Is XVIPF a Buy, Hold, or Sell?
Based on XVIPF’s technical indicators, XVIPF is a Buy.
    What is XVIPF’s RSI (14)?
    XVIPF’s RSI (14) is 62.08, which suggests XVIPF is a Neutral.
      What is XVIPF’s MACD?
      XVIPF’s MACD is 0.09, which suggests XVIPF is a Sell.
        What is XVIPF’s 5-day moving average?
        XVIPF’s 5-day moving average is 18.92, which suggests XVIPF is a Buy.
          What is XVIPF’s 20-day moving average?
          XVIPF 20-day moving average is 18.25, which suggests XVIPF is a Buy.
            What is XVIPF’s 50-day moving average?
            XVIPF’s 50-day moving average is 18.42, which suggests XVIPF is a Buy.
              What is XVIPF’s 200-day moving average?
              XVIPF’s 200-day moving average is 26.51, which suggests XVIPF is a Sell.
                What is XVIPF’s Williams % R (14)?
                XVIPF’s Williams % R (14) is -8.22, which suggests XVIPF is a Sell.
                  What is XVIPF’s CCI (14)?
                  XVIPF’s CCI (14) is 111.60, which suggests XVIPF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis